THOMAS ROESCH: Open Payments
NPI 1245206929 · BRYN MAWR, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 22 payments from 11 companies in 2025. Trend: 2023 $234 · 2024 $563 · 2025 $528
Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $115 |
| AstraZeneca Pharmaceuticals LP | 4 | $95 |
| Novartis Pharmaceuticals Corporation | 3 | $77 |
| Daiichi Sankyo Inc. | 3 | $56 |
| Caris MPI, Inc. | 2 | $52 |
| SOBI, INC | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Incyte Corporation | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $23 |
| Solventum Corporation | 1 | $16 |
Products named: KEYTRUDA, TAGRISSO, Fabhalta, MI CANCER SEEK, Enhertu, LYNPARZA, Vonjo, Nubeqa.
Industry payments across PA — which companies pay providers there.
